Lungpacer Medical’s AeroNova diaphragm neurostimulation system significantly reduced pulmonary hypertension (PH) among critically ill patients with lung failure…
Articles by Steve Bryson, PhD
Blocking GLS1, an enzyme that drives pro-inflammatory immune macrophages, reduces the signs and symptoms of pulmonary arterial hypertension (PAH)…
Anoikis, a form of programmed cell death, is involved in the development of chronic thromboembolic pulmonary hypertension (CTEPH), according…
Men with pulmonary arterial hypertension (PAH) have a larger right heart size and worse survival rates than women, independent…
The dosing regimen for Winrevair (sotatercept-csrk) is optimal for balancing efficacy and safety in adults with pulmonary arterial…
Cereno Scientific said it has enrolled nine additional people with pulmonary arterial hypertension (PAH) in its expanded access…
Lung tissue and cells from the blood vessels that pass through the lungs derived from people with pulmonary arterial…
LungFit PH, Beyond Air’s device for administering nitric oxide therapy, has received European CE mark approval for persistent…
Winrevair (sotatercept-csrk) significantly reduced the risk of all-cause death, a lung transplant, or hospitalization among adults with pulmonary…
Cereno Scientific has secured loan financing to continue developing CS1, its lead therapeutic candidate for pulmonary arterial hypertension…
Differences in Uptravi (selexipag) maintenance doses have no impact on the risk of hospitalization among adults with pulmonary…
People with pulmonary hypertension (PH) see worse outcomes following surgery to correct a hip fracture, a study shows. Among…